FDA Clearance Tracker · P830061-S144
CapSureFix Novus MRI SureScan Lead (4074 and 4574)
Last checked: Nov 20, 2026Latest source record: Aug 3, 2017 (this decision)Source: openFDAMethods & limitations
Decided
Aug 3, 2017
Approved
Time to decision
122 days
Received Apr 3, 2017. Calendar days, including time FDA spent waiting on the applicant.
Pathway
PMA supplement
Normal 180 Day Track
Device class
Class III
The decision
- FDA number
- P830061-S144
- Device name
- CapSureFix Novus MRI SureScan Lead (4074 and 4574)
- Applicant
- Medtronic, Inc.
- Applicant location
- Mounds View, MN
- Received
- Apr 3, 2017
- Decided
- Aug 3, 2017
- Decision
- Approved
- Supplement type
- Normal 180 Day Track
- Reason for supplement
- Change Design/Components/Specifications/Material
- Original approval
- P830061
Device type
- Device type
- Drug eluting permanent right ventricular (RV) or right atrial (RA) pacemaker electrodes (NVN)
- Device class
- Class III
- Specialty
- CardiologyElectrophysiology
FDA's approval statement
As written in FDA's record.
Approval for Attesta and Sphera devices.
Source documents
Other decisions for Medtronic, Inc.
Matched on the applicant name as FDA recorded it. A company that files under several names will have more.
K263596 · Decided Oct 29, 2026 · 29 days after receipt
Device type: Catheter, Cannula And Tubing, Vascular, Cardiopulmonary Bypass (DWF) · Cardiology
7 more FDA decisions with a free account
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.